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The most common recurrent cytogenetic abnormalities in T-lymphoblastic leukemia (T-
acute lymphoblastic leukemia [T-ALL]) involve T-cell receptor (TCR) loci and a variety of 
partner genes, including HOX11, HOX11L2, MYC, and TAL1. In this report, we present a 
rare case involving simultaneous translocation of the TCR α/δ loci with different partner 
loci (Xq22 and 12p13); this resulted in a poor prognosis. Chromosomal analysis showed 
46,Y,t(X;14)(q22;q11.2),t(12;14)(p13;q11.2) and FISH analysis by using a T-cell receptor 
alpha delta DNA probe, Split Signal (DakoCytomation, Denmark), showed translocations 
at the same TCR α/δ locus on both chromosomes. FISH with 2 bacterial artificial chromo-
some clones showed break apart signal, which suggests involvement of the IRS4 gene. To 
our knowledge, this is the first report of T-ALL in which both TCR α/δ loci were translocat-
ed with different partner loci, and 1 of the partner loci, Xq22, was a rare translocation part-
ner locus that included IRS4 gene.
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INTRODUCTION
T-lymphoblastic leukemia (T-cell acute lymphoblastic leukemia 
[T-ALL]), a highly malignant cancer derived from T-cell progeni-
tors, comprises 15% of acute lymphoblastic leukemia cases [1, 
2]. T-ALL is a genetically heterogeneous disease with transloca-
tions that usually involve recombination between T-cell receptor 
(TCR) loci and several different partner genes [3]. Most of these 
translocations result in deregulation of the partner genes that 
are located near TCR regulatory elements [4]. The most com-
mon partner genes are HOX11, HOX11L2, MYC, and TAL1. Con-
sequently, these partner genes, rather than the TCR, may play 
important roles in T-cell leukemogenesis. Translocations involv-
ing TCR loci are found in about 35% of T-ALL cases, and un-
identified partner genes are involved in 5-10% of cases [5]. This 
report presents a case of T-ALL in which the leukemic cells 
showed the simultaneous chromosomal abnormalities t(X;14)
(q22;q11.2) and t(12;14)(p13;q11.2). To our knowledge, this si-
multaneous translocation has not been previously reported, and 
Xq22 has been reported as a partner locus only once in child-
hood T-ALL [3].
CASE REPORT
A 27-yr-old man was admitted to our hospital complaining of 
headache, dizziness, nausea, and vomiting, which began 3 days 
before admission. No palpable lymph-node enlargement or hep-
atosplenomegaly was detected on physical examination. Labora-
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tory findings were as follows: white blood cell (WBC) count, 49.5
×10
9/L; hemoglobin level, 161 g/L; and platelet count, 36×10
9/
L. A peripheral blood smear showed that 95% of WBCs were 
blasts (Fig. 1A). The serum lactate dehydrogenase (LDH) level 
was markedly elevated to 13,022 IU/L. The patient’s bone mar-
row was nearly packed with small-to-medium sized leukemic 
cells with a high nuclear/cytoplasmic ratio, which was calculated 
as 93.2% (Fig. 1B, C). A biopsy showed hypercellularity with dif-
fuse infiltration of immature blast cells (Fig. 1D). Flow cytometry 
revealed that the leukemic blasts with intermediate CD45 ex-
pression and low side scatter (SSC) were positive for CD2, CD7, 
CD5, and CD3, and negative for TdT, CD34, CD13, CD33, CD10, 
CD19, CD20, and CD22. Therefore, the patient was diagnosed 
with T-ALL.
  The patient’s karyotype was 46,Y,t(X;14)(q22;q11.2),t(12;14)
(p13;q11.2) (Fig. 2). FISH analysis was performed to determine 
the breakpoints using a T-cell receptor alpha delta (TCRAD) 
DNA Probe, Split Signal (DakoCytomation, Glostrup, Denmark), 
and it revealed 2 red and 2 green abnormal signal patterns in 
89% of the cells, suggesting TCR α/δ rearrangements in both 
chromosomes. To map the Xq22 breakpoint, 2 bacterial artificial 
chromosome (BAC) clones, RP11-815E21 and RP11-105F23 
(Empire Genomics, Buffalo, NY, USA), were used [3], and break-
apart signal patterns were obtained, suggesting insulin receptor 
substrate (IRS)4 gene translocation (Fig. 3). Additional FISH 
analyses by using the LSI BCR/ABL Dual Color, Dual Fusion 
Translocation Probe (Vysis/Abbott Molecular, Des Plaines, IL, 
USA), the TEL/AML1 ES Dual Color Translocation Probe (Vysis/
Abbott Molecular), the LSI p16(9p21)/CEP 9 Dual Color Probe 
(Vysis/Abbott Molecular), the LSI MLL Dual Color, Break Apart 
Fig. 1. T-lymphoblastic leukemia. Peripheral blood smear containing leukemic cells (Wright’s stain,  ×200) (A). Bone marrow aspirate 
smear showing leukemic cells that are small-to-medium sized, with a high nuclear-to-cytoplasmic ratio (Wright-Giemsa stain, ×200 (B) and 
×1,000 (C)). Biopsy section showing hypercellularity with heavy infiltration of immature cells (H&E, ×100) (D).
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Fig. 3. FISH at initial diagnosis using the TCRAD DNA Probe, Split Signal (DakoCytomation, Glostrup, Denmark), which showed 2 red and 
2 green abnormal signals in metaphase (A) and interphase (B). A schematic diagram of the positions of RP11-815E21 and RP11-105F23 
at Xq22.3 (C). Start and end positions were acquired from NCBI36/hg18 assembly. FISH using RP11-815E21 and RP11-105F23 showing 
1 red and 1 green break-apart signal (D).
Abbreviation: TCRAD, T-cell receptor alpha delta. 
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Fig. 2. Karyotype at diagnosis showing 46,Y,t(X;14)(q22;q11.2),t(12; 
14) (p13;q11.2). Arrows indicate the rearranged chromosomes.
Rearrangement Probe (Vysis/Abbott Molecular), and the LSI 
MYC Dual Color, Break Apart Rearrangement Probe (Vysis/Ab-
bott Molecular) showed no abnormal signals.
  The patient was treated with hyper-CVAD (cyclophosphamide, 
vincristine, adriamycin, and dexamethasone) as the first course 
of induction chemotherapy. Complete remission was achieved 
after 1 month and was confirmed by normal TCRAD FISH sig-
nals. At that time, the patient’s karyotype was 46,XY [20]. Next, 
the patient was treated with high-dose methotrexate/cytarabine 
(HD MTx/Ara-C) as the first course of consolidation therapy, hy-
per-CVAD as the second consolidation therapy, and then alloge-
neic peripheral blood stem cell transplantation (allo-PBSCT) 
was performed. However, a central nervous system (CNS) re-
lapse was diagnosed 1 yr later, and the patient died of sepsis 
while receiving induction chemotherapy 1 month after relapse. Kang D-H, et al.
t(X;14) and t(12;14) in T-ALL
223 http://dx.doi.org/10.3343/alm.2012.32.3.220 www.annlabmed.org
DISCUSSION 
T-ALL is a malignant proliferation of T-lymphoid blasts, and 50-
70% of cases have abnormal karyotypes [2, 6]. The chromo-
somal rearrangements in T-ALL typically involve breakpoints in 
bands where TCR genes are located, including 14q11 (TCR-α 
and TCR-δ), 7q32-36 (TCR-β), and 7p15 (TCR-γ) [2, 7]. During 
V(D)J recombination in T-cell development, several genes tran-
scribed at an early stage of thymocyte development are in an 
“open” chromatin configuration and are vulnerable to the action 
of recombinases. Consequently, illegitimate recombination may 
place target partner genes next to TCR regulatory sequences. 
This may lead to their aberrant expression in developing thymo-
cytes, thus leading to T-ALL, with differentiation blocked at vari-
ous stages of maturation [5]. Commonly involved partner genes 
of TCR loci include the transcription factors HOX11 (TLX1) 
(10q24), HOX11L2 (TLX3) (5q35), MYC (8q24.1), TAL1 (1p32), 
TAL2 (9q32), LYL1 (19p13), LMO1 (11p15), and LMO2 (11p13), 
and the cytoplasmic tyrosine kinase LCK (1p34.3-35) [6, 8-10].
  Simultaneous rearrangements targeting TCR-β and -α loci are 
observed in 4% of patients with T-ALL, possibly reflecting a 
higher susceptibility to errors in V(D)J recombination [11]. In 
this study, we described a case of T-ALL with simultaneous 
translocation of both TCR α/δ loci (14q11) to different partner 
loci (Xq22 and 12p13). From a molecular perspective, Xq22 and 
12p13 were juxtaposed with the TCR α/δ loci (14q11). Break-
points within the TCR α/δ locus occur in more than 20% of T-
ALL cases with abnormal karyotypes, and the mechanism un-
derlying these translocations most likely involves illegitimate 
V(D)J recombination [4, 12, 13].
  In several T-ALL cases, t(12;14)(p13;q11) has been observed 
in association with the CCND2 gene, which is thought to stimu-
late cellular proliferation via cell cycle activation [1, 4]. The Xq22 
locus is a rare partner gene, and to our knowledge, has been 
reported only once by Karrman et al. [3] in a pediatric case of T-
ALL in which Xq22 was translocated to 7q34 (TCR-β). There is 
no report of adult T-ALL involving the translocation of Xq22 and 
TCR α/δ. The molecular genetic characterization of t(X:7) re-
vealed the IRS4 gene [3, 14]. 
  Although an additional study was not available in our case, 
FISH using the RP11-815E21 and RP11-105F23 BAC probes 
(Empire Genomics) at Xq22.3 showed a break-apart signal pat-
tern, suggesting IRS4 gene translocation. The exact role of IRS4 
remains unclear; however, IRS proteins mediate signaling from 
insulin and insulin-like growth factor 1 receptors, and have im-
portant effects on cell growth and survival [15]. 
  In rarely observed cytogenetic abnormalities, it is difficult to 
uncover any relationship with prognosis. In a UK-US collabora-
tive group study of 356 adult T-ALL cases, the remission rate 
was over 90%, and the 5-yr survival rate was approximately 50% 
[16]. However, considering that in the case reported by Karrman 
et al. [3] the patient relapsed and died about 2 yr after diagno-
sis, and the outcome in our case, where the patient relapsed 
and died about 1 yr after the initial diagnosis, IRS4 gene involve-
ment may be related to a poor prognosis.
  In conclusion, this is the first case report of T-ALL in which 
both TCR α/δ loci (14q11) were translocated simultaneously to 
different partner loci. One of these partner loci, Xq22, was rare 
and was found to involve IRS4, which may have an important 
effect on cell growth and survival, and to be associated with a 
poor prognosis.
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